Evaluation of results of chemotherapy in tuberculosis with special consideration of ethambutol.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003523:Cycloserine / Q000627:therapeutic use; D004338:Drug Combinations; D001330:Electronic Data Processing; D004977:Ethambutol / Q000627:therapeutic use*; D005000:Ethionamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D004338:Drug Combinations; D013882:Thiosemicarbazones; D011718:Pyrazinamide; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin